Last week was quite a week! Congratulations to Martin Babler & the team at Alumis on their IPO. Alumis was incubated by Foresite Labs; the company is developing two Tyrosine Kinase 2 inhibitor product candidates for patients living with immune-mediated diseases who need alternatives to existing treatments. This achievement represents years of work from the therapeutics team at Foresite Capital and the incubation team at Foresite Labs. Congrats to all!
Foresite Labs
Biotechnology
San Francisco, California 4,092 followers
A center for entrepreneurial innovation at the nexus of data science and healthcare
About us
Foresite Labs incubates companies that will address some of our greatest unmet medical needs. Their experienced team of scientists, engineers, and operators believes that the tools of data science, when applied with scientific rigor, will greatly accelerate scientific discovery and the development of new products and services that benefit patients. Through its incubation platform, Foresite Labs is dismantling the barriers faced by visionary entrepreneurs and their companies as they seek to re-invent healthcare. Foresite Labs Values Truth over progression: We follow the science, pursuing ideas that are grounded in data and abandoning them when not supported by the evidence. Take good risks: Our culture values informed risk-taking: good decisions are celebrated even when they result in bad outcomes. Everyone feels safe to contribute ideas and to learn from failure. Single accountable person: The project team lead is accountable for all decisions and for maintaining transparency and information flow within the team; we trust the project teams. The Review Committee unlocks capital and sets directions. Simplicity and Focus: “Companies die from indigestion, not starvation” (Bill Hewlett) We will focus on a few ideas aggressively and minimize all other distractions. Everyone will have a few key goals that have measurable outcomes. Respect and Community: Our employees are our greatest asset; everyone invests in creating an environment of collaboration and respect. We support their careers and career development whether they stay, go to a Labs company, or end up somewhere else.
- Website
-
http://www.foresitelabs.com
External link for Foresite Labs
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- San Francisco, California
- Type
- Privately Held
- Founded
- 2019
Locations
-
Primary
601 California St
Suite 600
San Francisco, California 94108, US
-
625 Massachusetts Ave
2nd Floor
Cambridge, MA 02139, US
Employees at Foresite Labs
Updates
-
Our CEO Vik Bajaj is at HLTH Europe and will be speaking at the Touch Stage at 12:20 PM CEST for the panel discussion “Square peg, square hole - Unleashing the potential of genomics and personalized therapies”. Join him and industry experts Jason C. Foster, Dana Mendenhall, Benjamin Zaniello, MD MPH w/ moderator Rabab Nasrallah, PhD to learn about the potential that new therapies will have on the healthcare system as we know it. More about HLTH Europe here: https://europe.hlth.com/
-
Proud of our colleagues at Foresite Capital on the close of Fund VI, which has invested in our incubated companies Alumis and Xaira Therapeutics, among many other companies at all stages working to solve great unmet medical needs. Hats off to the team! #lifesciences #venturecapital
Foresite raises $900M to make big bets in 'one of the best biotech investment environments'
fiercebiotech.com
-
A helpful primer on pronunciation of our incubated company Xaira Therapeutics.
We have a special guest who joined the Xaira Pronunciation Nation for today's lesson. Say hello to Clifford and his friend, multi-omics scientist and hairbrush mic pro Bianca Ynez Ruiz Smith. Excellent job, Clifford and Bianca! 12/10. We wish everyone a happy long weekend and start of summer. Enjoy the time with your friends and family -- furry or otherwise. And take the time to check out our open roles if you're interested in joining us!
-
Foresite Labs reposted this
I have an open position on my team for an experienced statistical and translational geneticist with a desire to apply his/her skills to biotech incubation. Want to learn about new venture creation and work with a team experienced in generating insights that can be used to improve patient lives? Let’s talk!
Associate Director/Director, Statistical and Translational Genomics
boards.greenhouse.io
-
Attending Fortune Brainstorm Health? Don’t miss our CEO Vik Bajaj’s panel discussion “Powering Research and Development with AI” tomorrow at 8:00 a.m. pacific. Vik will explore the ways that AI is driving advancements in drug discovery alongside industry experts David Del Bourgo, Tina Marriott, Anna Marie Wagner and moderator Andrew Nusca. Learn more about Fortune Brainstorm Health here: https://lnkd.in/g6rYmKtr #FortuneBrainstormHealth #ForesiteLabs
FORTUNE BRAINSTORM Health 2024
fortune.com
-
Congratulations to Foresite Labs senior associate Tim Aikin from our new ventures team on the recent publication of two papers he co-authored in Developmental Cell and Science with Sergi Regot, Connor McKenney, and Adler Guerrero Zuniga. Way to go, Tim! Whole genome doubling is a frequent and poorly understood event during cancer evolution. In these works, the team explored the role of common oncogenes and various cell stressors in promoting cell cycle exit and genome doubling. Check out the papers below. https://lnkd.in/gZWfCsYb https://lnkd.in/g9SvNJxD
Sustained ERK signaling promotes G2 cell cycle exit and primes cells for whole-genome duplication
sciencedirect.com
-
A big Foresite Labs welcome to Waael Zahriya, who joins us as people operations generalist! Waael will be helping ensure that all our current and future teammates are well taken care of, and we're glad to have him on our team.
-
-
Great progress at our incubated company Alumis. Congrats to the team on this progress.
Today we announced that the first participant has been dosed in our Phase 1 clinical trial of A-005, a potential first-in-class, CNS penetrant TYK2 inhibitor for the treatment of neuroinflammatory and neurodegenerative diseases. Learn more: https://lnkd.in/gATWAT_q #TYK2 #CNS
-
-
The countdown to the Longwood Healthcare Leaders Miami CEO retreat begins! Next Tuesday April 30th at 10:30 a.m., our CEO, Vik Bajaj, will share tips alongside James H., Rachel Mears, Heather Preston, and David Steinberg for CEOs and founders on how to effectively collaborate with their board. These executives bring a total of 130+ years of healthcare experience and will speak to common challenges biopharma leaders face, how to navigate them, and the key to a great relationship with your board. If you’re attending the event, be sure to stop by! Learn more about the retreat here: https://lnkd.in/eQaWd8TU #Biopharma #BiopharmaInvestors #CEO #Conference
Miami CEO, Ritz Carlton, April 29-May 1 | Longwood Healthcare Leaders
longwoodhealthcareleaders.com